Brief: Protara Therapeutics Q3 EPS USD -0.31
10/11/2025 13:00
Nov 10 (Reuters) - Protara Therapeutics Q3 operating expenses USD 14.76 million. Q3 income from operations USD -14.76 million Q3 net income USD -13.258 million
Recent news on Protara Therapeutics
See all newsProtara Therapeutics Inc reports results for the quarter ended June 30 - Earnings Summary
Protara Therapeutics Q2 net loss widens on higher expenses
Brief: Protara Therapeutics - Enters Sales Agreement With TD Cowen For Common Stock Offering
Brief: Protara Therapeutics Announces Positive Updated 12-Month Data Demonstrating Durable Responses
Protara Therapeutics Q1 net loss widens on higher expenses